Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis

NCT03327909 is registered in ClinicalTrials.gov with Stanford University as lead sponsor.

NCT NCT03327909
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03327909 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Timing of Antihypertensive Medications on Key Outcomes in Hemodialysis
Lead sponsor
Stanford University
Phase
Not applicable
Overall status
Completed
Start date
July 16, 2018
Completion date
December 14, 2019
Enrollment
131 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

blood pressure, esrd, hemodialysis complication